Description
Somatropin is a synthetic 191-amino acid peptide hormone identical to endogenous human growth hormone (hGH) produced by the pituitary gland. It plays a crucial role in cellular regeneration, tissue repair, and metabolism regulation. Recombinant HGH is widely studied for its impact on protein synthesis, bone density, and lipid mobilization, and is considered a benchmark molecule in research exploring the mechanisms of growth, recovery, and anti-aging physiology.
Formulated in a stabilized pre-mixed injection pen for SubQ administration, this version of HGH ensures high bioavailability and ease of dosing in controlled environments. The delivery format allows consistent absorption and minimizes degradation, supporting more accurate modeling of anabolic and metabolic effects in research settings.
In experimental models, Somatropin has been observed to upregulate IGF-1 production, enhance nitrogen retention, and accelerate collagen synthesis, suggesting a multifaceted influence on muscle hypertrophy and tissue resilience. The peptide has also demonstrated lipolytic and glucose-modulating properties, aligning with its potential role in metabolic and longevity research protocols.
Clinical Status: HGH (Somatropin) is FDA-approved for human growth hormone deficiency, Turner syndrome, and cachexia, but all other uses remain investigational.
Evidence type: Human RCT ✔ | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory ✔
Mechanism of Action
Somatropin engages tyrosine kinase-linked GHRs, triggering phosphorylation cascades involving JAK2, STAT5, and MAPK/ERK pathways. These cascades modulate gene transcription responsible for cell proliferation, differentiation, and repair. Additionally, HGH indirectly influences insulin-like growth factor (IGF-1) production, which mediates anabolic effects across skeletal muscle, bone, and connective tissues. The combined activation of PI3K/Akt and mTOR pathways promotes hypertrophic and anti-catabolic effects, while its regulation of lipolytic enzymes supports increased fat oxidation and energy redistribution.
Benefits
Stimulation of Growth and Cellular Regeneration: HGH (Somatropin) is studied for its ability to stimulate cellular growth, repair, and regeneration across multiple tissues, including muscle, bone, and skin. Acting through IGF-1 and growth hormone receptors, it promotes protein synthesis, accelerates recovery from physical stress, and enhances tissue renewal. These effects make it a cornerstone of research on longevity, recovery, and systemic rejuvenation. Increase in Lean Muscle Mass and Strength: HGH has been observed to increase lean body mass by enhancing amino acid uptake and stimulating myocyte growth. In athletic and clinical research, this translates to improved muscle density, endurance, and physical strength. Its role in anabolic signaling and tissue repair has positioned it as a leading compound in performance and recovery studies. Reduction of Adipose Tissue and Improved Body Composition: Research models show that Somatropin stimulates lipolysis by activating hormone-sensitive lipase, promoting fat oxidation while preserving lean tissue. Long-term studies demonstrate a reduction in visceral and subcutaneous fat, resulting in improved metabolic efficiency and body composition optimization. Regulation of Metabolic and Endocrine Balance: HGH plays a crucial role in maintaining glucose and lipid metabolism through modulation of insulin-like growth factor (IGF-1). It supports glycogen synthesis, fatty acid oxidation, and optimal energy distribution between tissues. This systemic regulation is central to its study in metabolic health and endocrine function optimization. Enhanced Bone Density and Skeletal Health: Somatropin enhances osteoblast proliferation and calcium retention, improving bone density and mineralization in aging and growth models. It also promotes collagen synthesis within the skeletal matrix, contributing to stronger bone architecture and reduced risk of structural degeneration over time. Improved Recovery and Tissue Healing: HGH is studied for its accelerated wound and tissue healing properties, attributed to increased collagen production and enhanced fibroblast activity. This regenerative capacity supports faster recovery following injury, surgery, or strenuous physical activity, making it an essential peptide in musculoskeletal and orthopedic research. Support for Cardiovascular and Lipid Health: Research suggests that HGH improves cardiovascular function by enhancing cardiac output, vascular elasticity, and lipid metabolism. It lowers LDL cholesterol and triglycerides while promoting nitric oxide synthesis, supporting vascular integrity and overall heart health in long-term metabolic studies. Improved Cognitive Function and Mood: Studies indicate that Somatropin may have neurocognitive and mood-enhancing effects due to its influence on neurogenesis and neurotransmitter balance. Increased IGF-1 signaling supports neuronal growth, cognitive sharpness, and improved sleep quality, aligning with its exploration in neuroendocrine and anti-aging research. Restoration of Skin Elasticity and Youthful Appearance: HGH stimulates dermal collagen and elastin synthesis, improving skin thickness, hydration, and elasticity. These dermatological effects contribute to smoother skin texture and reduced visible signs of aging, forming a strong research link between Somatropin and regenerative aesthetics. Enhancement of Immune Function and Longevity: Somatropin supports immune system efficiency by promoting lymphocyte proliferation and cytokine regulation. It is also studied for its role in extending cellular lifespan through mitochondrial support and DNA repair activation, making it a fundamental peptide in aging and vitality research. Synergistic Potential with Peptides and NAD+: In experimental settings, HGH is often combined with CJC-1295, Ipamorelin, or NAD+ to enhance growth hormone pulsatility, mitochondrial energy production, and systemic rejuvenation. These synergistic protocols are used to investigate comprehensive anti-aging and recovery models in advanced peptide research.
Research Data
Study/model Reported effect Human clinical trials (GH-deficient adults)
↑ lean body mass (~3.5 kg) and ↓ fat mass (~2.0 kg) after 6 months of administration Human clinical trials (elderly population)
↑ skin thickness and elasticity; improved collagen deposition Animal models (fracture healing)
Accelerated callus formation and ↑ osteoblast activity Preclinical wound healing studies
Enhanced fibroblast proliferation and collagen synthesis Metabolic research (human)
Improved lipid profile (↓ LDL, ↑ HDL) and glucose utilization Exercise recovery studies
Shortened muscle recovery time and increased performance capacity In vitro studies (cell culture)
Upregulated STAT5 signaling and IGF-1 gene expression Long-term administration models
Sustained increase in protein turnover and mitochondrial activity
Stack Suggestions
HGH is commonly stacked with:
IGF-1 LR3 – direct muscle growth, synergy for cell proliferation BPC-157, TB-500 – accelerated recovery/regeneration of injury or after intense training, cytoskeletal/angiogenic complement Epitalon – cell renewal, telomere support SS-31 – mitochondrial antioxidant for deeper tissue repair NAD+ – cellular energy, anti-age and metabolism enhancement
Stacks discussed are for experimental design not safety/efficacy guidance.
Pen Dosage Chart
HGH Somatropin Pen 24 IU Volume 2.0 mL mg/mL 12 IU/mL Click-to-Dose 1 click = 0.12 IU Example(s) 8 clicks = 0.96 IU
HGH Somatropin Pen 36 IU Volume 3.0 mL mg/mL 12 IU/mL Click-to-Dose 1 click = 0.12 IU Example(s) 8 clicks = 0.96 IU
Dosage & Protocols Variations
Standard Research Protocol
Dose: 1 – 2 IU (= 8–17 clicks) Duration: 8 – 12 weeks Frequency: 1× daily Cycle Interval: 4 week rest Goal / Description: Commonly used for studying anabolic and metabolic regulation
High-Intensity Regeneration
Dose: 3 – 5 IU (= 25–42 clicks) Duration: 8 – 12 weeks Frequency: 1× daily Cycle Interval: 8 week rest Goal / Description: Used in experimental designs focused on tissue and recovery response
Pulsed Night Protocol
Dose: 1.5 – 2.5 IU (= 13–21 clicks) Duration: 8 – 12 weeks Frequency: Every Other Day Cycle Interval: 4 week rest Goal / Description: Mimics physiological nocturnal GH release cycles
Possible Side Effects
HGH, as a research hormone promoting growth, may induce various side effects in experimental models, primarily related to fluid and metabolic shifts. These are dose-dependent and prominent at higher levels. Monitoring is crucial for subcutaneous administration.
Peripheral Edema: Commonly observed as swelling in limbs, due to sodium retention via IGF-1. It subsides with adaptation or dose reduction.
Joint Pain and Arthralgias: Mild discomfort in joints, linked to rapid tissue growth and cartilage changes. Frequency decreases in slower protocols.
Carpal Tunnel Syndrome: Nerve compression symptoms like tingling, attributed to soft tissue expansion. Resolves post-treatment.
Headache: Transient, possibly from intracranial pressure or vascular effects.
Insulin Resistance: Altered glucose tolerance, with potential hyperglycemia in models. Managed by monitoring.
Fatigue: Early lethargy from metabolic adjustments.
Most side effects are transient and manageable through adjustments. Prolonged use warrants vigilance for acromegaly-like changes or cardiovascular strain, though rare in controlled settings.
Product Attributes
CAS #: 12629-01-5 Molecular Formula: C990H1529N263O299S7 Sequence (AA): Full-length synthetic human growth hormone, 191 amino acids Molecular Weight: ~22,125 g/mol Half-Life: 2 – 4 hours Synonyms: Somatotropin, rhGH, Human Growth Hormone, Genotropin, Humatrope, Norditropin Type: Recombinant peptide hormone identical to endogenous hGH Research Focus: Recovery & Performance
Scientific References
Growth hormone and cognitive function Review Growth hormone and aging: updated review Review Growth hormone Review Implantation of genetically engineered fibroblasts into mice Animal Growth hormone and surgery Animal Growth hormone in the brain Review Growth hormone releasing peptide-2 (GHRP-2), like ghrelin Human Changes in hormone levels and responses to stress after 4 months Animal Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone analog Animal Is growth hormone good for the heart? Review